Psychedelics Research Insights
A recent study explores the effects of psychedelics on healthy middle-aged volunteers, revealing intriguing insights into dosing and gender dynamics within research settings. The trial, which faced challenges due to COVID, compared the impact of psilocybin therapy with traditional antidepressants, highlighting the importance of standardized psychotherapy. Key findings suggest a nuanced understanding of microdosing and its role in therapeutic contexts.In this clip
From this podcast
Huberman Lab
Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health | Huberman Lab Podcast
Related Questions
Tell me more about the group that used mushrooms in the psilocybin vs Lexapro study from the episode Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health | Huberman Lab Podcast and the clip Psychedelics Research Insights. What was their dosing regimen and did they do psychotherapy while under the effects?
Tell me more about the group that used mushrooms in the psilocybin vs Lexapro study - what was their dosing regimen and did they do psychotherapy while under the effects?
What are the details of the psilocybin vs Lexapro study that Andrew Huberman discusses?